ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
HB
HighField Biopharmaceuticals at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
HighField Biopharmaceuticals takes part in 3 sessions at ESMO 2026 in Madrid. Its work explores immune-based treatments for solid tumours, including engineered T cells and antibody-based drug delivery. One study targets pancreatic cancer with a PD-L1-directed drug carrying a KRAS-targeting molecule and irinotecan.
| Organization | ESMO 2026 Attendance |
|---|---|
HB HighField Biopharmaceuticals Hangzhou, China | |
Biopharmaceutical company developing cancer therapies in Hangzhou, China. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 |
Find decision makers at HighField Biopharmaceuticals
Tell us what you sell and we’ll find the people at HighField Biopharmaceuticals most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction